Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Purpose The aim of this study was to assess the effectiveness of long-term therapy with
multiply botulinum neurotoxin (BoNT) injections. Methods In 2004–2010, 60 children with …

A systematic review with the Sachett model of evidence-based medicine of the use of
Botulinum toxin type A (BTX) for intervention in children with Cerebral Palsy (CP) is …

Botulinum toxin type A (BoNT-A) therapy has gained wide acceptance in the management of
spasticity in cerebral palsy (CP). Clinical experience from numerous case reports and series …

Objective: To assess the efficacy of botulinum toxin A injection for the management of
spastic calf muscles in children with cerebral palsy. Data sources: We reviewed all relevant …

Therapeutic injections of botulinum toxin have been used for the past decade to decrease
muscle tone in children with cerebral palsy. Although this unique intervention has been …

Objective This study aimed to evaluate the effects of botulinum toxin A (BTX-A) treatment on
energy expenditure and ambulation in children with cerebral palsy (CP) and to determine if …

Objective: To determine if very low doses of botulinum toxin type A (BTX-A) could reduce
spasticity and improve gait in cerebral palsied children when combined with rehabilitation …

One of the main goals when treating spasticity is to relieve pain and improve function.
Intramuscular injection of botulinum toxin type A (BTX‐A) has gained widespread …

We prospectively studied the medium‐term effects of botulinum toxin type A (BTX‐A)
treatment in 197 children with cerebral palsy. Between one and four target muscles were …